We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Diagnosis of Cardiac Sarcoidosis Improved by Diet Prior to Imaging

By HospiMedica International staff writers
Posted on 28 Dec 2016
Researchers in the US have discovered that they can increase the certainty of diagnosing cardiac sarcoidosis, if from 72 hours until the diagnostic imaging exam the patients are subject to a high-fat, low-sugar diet.

Sarcoidosis is caused by the inflammation of a number of organs, including the lungs and lymph nodes, and can eventually affect the heart as well, and cause death from pulmonary fibrosis. More...
Cardiac Sarcoidosis is most often diagnosed using Positron Emission Tomography (PET) and Computed Tomography (CT) scans, and a radioactive tracer called fludeoxyglucose (FDG), but the results are sometimes difficult to interpret.

The researchers from the University of Illinois at Chicago (UIC; Chicago, Illinois, USA) published the results of their research online in the December 2016 issue of the journal Clinical Nuclear Medicine.

To reduce the amount of sugar taken up by healthy heart cells during the PET imaging, clinicians often give patients a high-fat, low-sugar diet for 24 hours before the scan. Healthy cells take up fat, while diseased cells take up the tracer and sugar, and are more easily detected in the scans. The UIC team then tried to use a 72-hour high-fat, low-sugar diet, before the scans, in 215 tests from 207 patients, in the study period between 2014 and 2015. The results showed that 42% of patients with the 24-hour diet had indeterminate results, compared to only 4% of patients with a 72-hour diet. The 72-hour diet enabled the researchers to conclude with a high degree of confidence whether the patients had cardiac sarcoidosis or not.

Corresponding author of the study, Dr. Yang Lu, assistant professor of radiology, UIC College of Medicine, said, "Up until now, diagnosis is made by expert opinion based on the results of several testing techniques including imaging. But what these scans show is often ambiguous, and so using them to definitively diagnose cardiac sarcoidosis is problematic. By following the diet for three days instead of one, the unpredictable but normal uptake of sugar by healthy heart cells was suppressed, so we could be more confident that areas that picked up the FDG had a very high likelihood of being affected by sarcoidosis, and this minimized the number of indeterminate findings where we can't make a diagnosis. The technique will also allow clinicians to better-follow their patients' progress under treatment for sarcoidosis."

Related Links:
University of Illinois at Chicago


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Patient Monitoring System
AlarmSense
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.